Manufacturer of pharmaceutical medicines, vaccines and consumer healthcare product, GlaxoSmithKline (GSK) has announced to restructure UK business due to manufacturing shake-up.
GSK’s corporate headquarters in Brentford, London – image courtesy of GSK. The company, with headquarters in Brentford, plans to invest more than £140m at its Ware, Hertfordshire, Barnard Castle, Co Durham and Montrose, Scotland sites from now until 2020, mainly to support expansion for production of respiratory and HIV medicines. This new investment…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
